Menzies Institute for Medical Research
@menzies-research.bsky.social
Research news, impact and more from Menzies, one of Australia’s leading health and medical research institutes.
Dr Nicholas Blackburn (@nickomatics.bsky.social) of our MS Research Flagship, and session chair at #MSResearchConf2025, expertly sets the scene for a deep dive into genetics, neurobiology and the disease mechanisms of #multiplesclerosis on day two of MS Australia's conference in Brisbane.
December 4, 2025 at 1:51 AM
Dr Nicholas Blackburn (@nickomatics.bsky.social) of our MS Research Flagship, and session chair at #MSResearchConf2025, expertly sets the scene for a deep dive into genetics, neurobiology and the disease mechanisms of #multiplesclerosis on day two of MS Australia's conference in Brisbane.
How does sleep quality affect work productivity for Australians living with #MultipleSclerosis? Professor van der Mei from our MS Research Flagship shares key findings from her research, including the potential benefit of developing a sleep intervention, at #MSResearchConf2025
December 3, 2025 at 7:21 AM
How does sleep quality affect work productivity for Australians living with #MultipleSclerosis? Professor van der Mei from our MS Research Flagship shares key findings from her research, including the potential benefit of developing a sleep intervention, at #MSResearchConf2025
Congrats to our PhD student Panteha Khaledi on her fantastic presentation at MS Australia’s #MSResearchConf2025! Her work, in collaboration with QIMR Berghofer, explores T cell immunity and Epstein-Barr virus in #MultipleSclerosis, and reveals exciting progress in understanding this complex disease.
December 3, 2025 at 5:11 AM
Congrats to our PhD student Panteha Khaledi on her fantastic presentation at MS Australia’s #MSResearchConf2025! Her work, in collaboration with QIMR Berghofer, explores T cell immunity and Epstein-Barr virus in #MultipleSclerosis, and reveals exciting progress in understanding this complex disease.
"Multiple sclerosis is costing Australians more than $3b a year and number of people with MS up 77% since 2010" - Professor Bruce Taylor presents about the Health Economic Impact of MS in Australia report at MS Australia's Progress in MS Research Conference #MSResearchConf2025 #MS #multiplesclerosis
December 2, 2025 at 11:58 PM
"Multiple sclerosis is costing Australians more than $3b a year and number of people with MS up 77% since 2010" - Professor Bruce Taylor presents about the Health Economic Impact of MS in Australia report at MS Australia's Progress in MS Research Conference #MSResearchConf2025 #MS #multiplesclerosis
We’re thrilled to see Dr Foong share his expertise on this global stage at #PACTRIMS. Over 50% of people with #MS are aged over 50, and his research is helping to shape their care. Dive into his team's latest papers here:
🔗 jnnp.bmj.com/content/earl...
🔗 journals.sagepub.com/doi/full/10....
🔗 jnnp.bmj.com/content/earl...
🔗 journals.sagepub.com/doi/full/10....
November 16, 2025 at 8:47 AM
We’re thrilled to see Dr Foong share his expertise on this global stage at #PACTRIMS. Over 50% of people with #MS are aged over 50, and his research is helping to shape their care. Dive into his team's latest papers here:
🔗 jnnp.bmj.com/content/earl...
🔗 journals.sagepub.com/doi/full/10....
🔗 jnnp.bmj.com/content/earl...
🔗 journals.sagepub.com/doi/full/10....
👏 Huge congratulations to Dr Yi Chao Foong @ycfoong.bsky.social from our MS Research Flagship! On the final day of #PACTRIMS in Osaka 🇯🇵 he shared his important work on treating older people with #multiplesclerosis based on real-world data from the MSBase registry 🌏 #MSResearch #PACTRIMS2025
November 16, 2025 at 8:47 AM
👏 Huge congratulations to Dr Yi Chao Foong @ycfoong.bsky.social from our MS Research Flagship! On the final day of #PACTRIMS in Osaka 🇯🇵 he shared his important work on treating older people with #multiplesclerosis based on real-world data from the MSBase registry 🌏 #MSResearch #PACTRIMS2025
TAURUS 2 recruited 100+ people with #MS across six Australian sites to test rTMS safety & early efficacy. This research is a big step toward identifying better MS treatments. Learn more about our work: msresearchflagship.org.au
November 14, 2025 at 4:25 AM
TAURUS 2 recruited 100+ people with #MS across six Australian sites to test rTMS safety & early efficacy. This research is a big step toward identifying better MS treatments. Learn more about our work: msresearchflagship.org.au
Professor Bruce Taylor from our #MS Research Flagship is in Osaka 🇯🇵 for the 17th #PACTRIMS Congress! He shared results from TAURUS 2, a phase II randomised controlled clinical trial exploring magnetic brain stimulation (rTMS) as a treatment for #MultipleSclerosis.
November 14, 2025 at 4:25 AM
Professor Bruce Taylor from our #MS Research Flagship is in Osaka 🇯🇵 for the 17th #PACTRIMS Congress! He shared results from TAURUS 2, a phase II randomised controlled clinical trial exploring magnetic brain stimulation (rTMS) as a treatment for #MultipleSclerosis.
We wish to congratulate Michael Whittle, a valued member of our Cardiovascular Research Flagship’s Lived Experience Advisory Group, who was announced last night as the Volunteer of the Year at the National Stroke Awards 2025.
October 30, 2025 at 5:26 AM
We wish to congratulate Michael Whittle, a valued member of our Cardiovascular Research Flagship’s Lived Experience Advisory Group, who was announced last night as the Volunteer of the Year at the National Stroke Awards 2025.
Dr@rachelclimie.bsky.social, from our Cardiovascular Research Flagship, recently represented our team at the Artery Society Conference in Valencia, Spain. She presented her team’s important work on vascular ageing in youth, vital work for understanding and preventing cardiovascular disease late life
October 21, 2025 at 6:38 AM
Dr@rachelclimie.bsky.social, from our Cardiovascular Research Flagship, recently represented our team at the Artery Society Conference in Valencia, Spain. She presented her team’s important work on vascular ageing in youth, vital work for understanding and preventing cardiovascular disease late life
Tomorrow is Ride2Work day! Our research shows that a lack of physical activity is a major risk factor for many chronic conditions. But small lifestyle changes like cycling to work is a great way to incorporate physical activity into your day! We are proud to pledge our support to Ride2Work Day 2025
October 14, 2025 at 6:19 AM
Tomorrow is Ride2Work day! Our research shows that a lack of physical activity is a major risk factor for many chronic conditions. But small lifestyle changes like cycling to work is a great way to incorporate physical activity into your day! We are proud to pledge our support to Ride2Work Day 2025
Isis Loos, a PhD candidate with our Cardiovascular Research Flagship, whose research is part of Communities for Walkability project, recently spoke to the U3A, Rosny, sharing data insights into how walking more can shape healthier communities. Sharing our research is an important part of what we do!
October 8, 2025 at 9:59 PM
Isis Loos, a PhD candidate with our Cardiovascular Research Flagship, whose research is part of Communities for Walkability project, recently spoke to the U3A, Rosny, sharing data insights into how walking more can shape healthier communities. Sharing our research is an important part of what we do!
Congrats to Dr Serah Kalpakavadi on delivering her final PhD seminar, under the supervision of Prof Seana Gall in the Cardiovascular Research Flagship! Her research, “Better prediction of stroke through identifying preceding health service encounters,” is part ofan NHMRC-funded grant, STOPstroke.
October 2, 2025 at 4:56 AM
Congrats to Dr Serah Kalpakavadi on delivering her final PhD seminar, under the supervision of Prof Seana Gall in the Cardiovascular Research Flagship! Her research, “Better prediction of stroke through identifying preceding health service encounters,” is part ofan NHMRC-funded grant, STOPstroke.
By bringing together diverse voices, we’re working to ensure scientifically robust AND socially relevant research. These conversations are central to our co-design approach, and places lived experience at the heart of our strategy #CardiovascularResearch #CoDesign #LivedExperience #Researchworkshop
October 2, 2025 at 4:53 AM
By bringing together diverse voices, we’re working to ensure scientifically robust AND socially relevant research. These conversations are central to our co-design approach, and places lived experience at the heart of our strategy #CardiovascularResearch #CoDesign #LivedExperience #Researchworkshop
🟣 It’s the final day of #PainAwarenessMonth, so what better time to spotlight the invisible burden many people with #MultipleSclerosis carry.
A new study from our #MSResearch Flagship researchers found that 53% of over 1600 participants experience regular pain. 20% reported 5–10 different types.
A new study from our #MSResearch Flagship researchers found that 53% of over 1600 participants experience regular pain. 20% reported 5–10 different types.
September 30, 2025 at 10:37 AM
🟣 It’s the final day of #PainAwarenessMonth, so what better time to spotlight the invisible burden many people with #MultipleSclerosis carry.
A new study from our #MSResearch Flagship researchers found that 53% of over 1600 participants experience regular pain. 20% reported 5–10 different types.
A new study from our #MSResearch Flagship researchers found that 53% of over 1600 participants experience regular pain. 20% reported 5–10 different types.
Congratulations to Dr Yuan Zhou of our #MultipleSclerosis Flagship who expertly presented on his multi-omics approach to investigating the Epstein-Barr virus EBV-MS connection to the world stage at the International Multiple Sclerosis Genetics Consortium (IMSGC) meeting in Barcelona, Spain. #EBV #MS
September 28, 2025 at 11:48 PM
Congratulations to Dr Yuan Zhou of our #MultipleSclerosis Flagship who expertly presented on his multi-omics approach to investigating the Epstein-Barr virus EBV-MS connection to the world stage at the International Multiple Sclerosis Genetics Consortium (IMSGC) meeting in Barcelona, Spain. #EBV #MS
👏Proud to see our MS Research Flagship researchers contribute to the EBV-MS consortium meeting at #ECTRIMS2025 in Barcelona—sharing ideas, bringing the Australian perspective, building global connections & advancing research into EBV’s role in MS.
#MSResearch #EBV #MSAustralia #GlobalCollaboration
#MSResearch #EBV #MSAustralia #GlobalCollaboration
September 28, 2025 at 11:10 PM
👏Proud to see our MS Research Flagship researchers contribute to the EBV-MS consortium meeting at #ECTRIMS2025 in Barcelona—sharing ideas, bringing the Australian perspective, building global connections & advancing research into EBV’s role in MS.
#MSResearch #EBV #MSAustralia #GlobalCollaboration
#MSResearch #EBV #MSAustralia #GlobalCollaboration
Can high-efficacy treatments improve outcomes for people diagnosed with #MultipleSclerosis later in life? Dr Yi Chao Foong @ycfoong.bsky.social from our #MSResearch Flagship explores this in his poster at #ECTRIMS2025
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
September 26, 2025 at 1:14 AM
Can high-efficacy treatments improve outcomes for people diagnosed with #MultipleSclerosis later in life? Dr Yi Chao Foong @ycfoong.bsky.social from our #MSResearch Flagship explores this in his poster at #ECTRIMS2025
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
What impact do #MultipleSclerosis treatments, particularly B cell therapies, have on Epstein-Barr virus activity? Our MS Research Flagship's Dr Chhavi Asthana presents her poster investigating that @ #ECTRIMS2025 🔗msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MSResearch
#MSResearch
September 26, 2025 at 12:57 AM
What impact do #MultipleSclerosis treatments, particularly B cell therapies, have on Epstein-Barr virus activity? Our MS Research Flagship's Dr Chhavi Asthana presents her poster investigating that @ #ECTRIMS2025 🔗msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MSResearch
#MSResearch
Our MS Research Flagship's Panteha Khaledi presents her poster at #ECTRIMS2025! Her study explores how the immune system’s T cells respond to Epstein-Barr virus (EBV) in people with #MultipleSclerosis
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MSResearch
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MSResearch
September 26, 2025 at 12:48 AM
Our MS Research Flagship's Panteha Khaledi presents her poster at #ECTRIMS2025! Her study explores how the immune system’s T cells respond to Epstein-Barr virus (EBV) in people with #MultipleSclerosis
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MSResearch
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MSResearch
Our MS Research Flagship's Himanshu Saraswat is at #ECTRIMS2025! His study investigated whether rare genetic variants in families with multiple MS cases could help explain MS risk.
More 👇
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
More 👇
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
September 25, 2025 at 3:06 AM
Our MS Research Flagship's Himanshu Saraswat is at #ECTRIMS2025! His study investigated whether rare genetic variants in families with multiple MS cases could help explain MS risk.
More 👇
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
More 👇
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
Dr Xin Lin from our MS Research Flagship is at #ECTRIMS2025! His poster reveals how genetic structural variation in complement component 4 affects risk of MS onset and disability progression.
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
September 25, 2025 at 3:01 AM
Dr Xin Lin from our MS Research Flagship is at #ECTRIMS2025! His poster reveals how genetic structural variation in complement component 4 affects risk of MS onset and disability progression.
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
Our MS Research Flagship's Prof Bruce Taylor is at #ECTRIMS2025! His poster explores how genetic oxidative stress and low Mediterranean diet intake combine to influence MS onset risk. More 👇
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
September 25, 2025 at 2:56 AM
Our MS Research Flagship's Prof Bruce Taylor is at #ECTRIMS2025! His poster explores how genetic oxidative stress and low Mediterranean diet intake combine to influence MS onset risk. More 👇
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
STOPstroke (Synergies TO Prevent stroke) is Australia’s 1st multi-disciplinary research initiative focused on preventing stroke. Recently, we hosted a workshop in Hobart- providing an opportunity for researchers to reflect on the program's impact + discuss the future of stroke prevention research.
September 21, 2025 at 12:47 PM
STOPstroke (Synergies TO Prevent stroke) is Australia’s 1st multi-disciplinary research initiative focused on preventing stroke. Recently, we hosted a workshop in Hobart- providing an opportunity for researchers to reflect on the program's impact + discuss the future of stroke prevention research.